Skip to main content
. 2020 Jul 8;319(3):L456–L470. doi: 10.1152/ajplung.00487.2019

Table 4.

Commonly activated or inhibited regulators in rat hypoxia lungs and human pulmonary arterial hypertension (67) lungs

Upstream Regulator Molecule Type Rat HH/RARA Lung
Human PAH/FD Lung
Adjusted P Value Activation z-Score Adjusted P Value Activation z-Score
β-Estradiol Chemical 2.27E-26 3.18E-16 Inhibited
Dexamethasone Chemical 2.54E-17 1.58E-14 Inhibited
Lipopolysaccharide Chemical 1.72E-23 Inhibited 5.64E-09
IFNG Cytokine 2.99E-12 Inhibited 4.09E-05
IL10 Cytokine 2.17E-09 7.91E-06 Inhibited
IL1B Cytokine 1.02E-14 Inhibited 1.13E-03
IL6 Cytokine 1.91E-16 6.59E-03
TNF Cytokine 7.82E-19 Inhibited 6.00E-11
TGFB1 Growth factor 5.11E-14 Inhibited 1.02E-08
ESR1 Receptor 2.24E-08 2.65E-06
ERBB2 Kinase 4.57E-09 Activated 2.08E-03
KLF2 Transcription regulator 5.23E-10 1.24E-02 Inhibited
NFKBIA Transcription regulator 2.99E-12 5.76E-03

Rat lung upstream regulators were compared with predictions from our recently published human PAH transcriptome data set (29). Expression of regulators in hypoxic rat lungs is compared with lungs from rats exposed to in utero and postnatal room air (HH/RARA). Expression of regulators from PAH lungs is compared with expression in failed lung transplant donor (FD) lungs. Adjusted P values indicate degree of pathway enrichment from the differentially expressed gene lists. Z-scores indicate predicted pathway direction with “Inhibited”/”Activated” indicating z-scores > |2.0|, and up or down arrows indicating z-scores < |2.0|. Note a global pattern of immune downregulation that is shared between rat and human, as well as common LPS, ESR1, ERBB2, and NFKBIA regulation patterns. HH, in utero and postnatal hypoxia; RARA, in utero and postnatal room air. See Table 2 for full names of regulators.